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ABSTRACT
Introduction: The use of assisted reproductive
technology (ART) procedures has increased globally over
the last three decades. Recent observational studies
suggest that children conceived through ART may be at
increased risk of asthma and atopic disease compared
with children conceived naturally, but findings are mixed.
We aim to synthesise the evidence on the impact of ART
on the risk of asthma and atopic disease in the offspring.
Methods and analysis: We will identify relevant
studies by searching MEDLINE, EMBASE, Cochrane
Library, ISI Web of Science, CINAHL, Scopus, Google
Scholar, AMED, Global Health, PsychINFO, CAB
International and the WHO Global Health Library from
1978 to 2016. We will locate additional studies through
searching databases of the proceedings of international
conferences, contacting international experts in the field,
and searching the references cited in identified studies.
We will include analytic observational studies (cohort
studies, case–control studies and cross-sectional
studies) that have investigated the impact of any type of
ART on offspring’s asthma and atopic disease. Screening
of identified records, data extraction from eligible studies
and risk of bias assessment of eligible studies will be
independently undertaken by two reviewers, with
arbitration by a third reviewer. The Effective Public Health
Practice Project will be employed for risk of bias
assessment. Estimates from studies judged to be
clinically, methodologically and statistically homogeneous
will be synthesised using random-effects meta-analysis.
Ethics and dissemination: As this study is based
solely on the published literature, no ethics approval is
required. We will publish our findings in a peer-reviewed
scientific journal and present the results at national and
international scientific conferences.
Protocol registration: We will register a detailed
protocol for the review with the International Prospective
Register of Systematic Reviews (PROSPERO) prior to
starting the review.
INTRODUCTION
Since its inception in 1978, the use of
assisted reproductive technology (ART) has
dramatically increased globally.1–6 It is now
estimated that ART accounts for between 1%
and 4% of all births, particularly in industria-
lised societies, but anecdotal data suggest
that its use is rising in low-income and
middle-income countries as well.1–6 Until
recently, in vitro fertilisation constituted the
majority of ART methods, but the use of
intracytoplasmic sperm injection has steadily
increased in recent times, and is now
believed to comprise up to 70% of all ART
procedures; the use of other procedures,
such as fresh and frozen embryo transfers
and intrauterine insemination, is steadily
increasing.1 2
Over the years, there have been concerns
about the short-term and long-term risks for
children conceived through ART compared
with those for naturally conceived chil-
dren.1 2 7 Children conceived through ART
are believed to phenotypically and biochem-
ically differ from those conceived naturally,
but the mechanisms underlying these differ-
ences and the subsequent health implica-
tions are unclear.2 Amidst conﬂicting
Strengths and limitations of this study
▪ As the use of assisted reproductive technology
becomes more common, clarifying its impact on
disease risk in offspring, such as risk of asthma
and allergy, is essential for decision-making.
▪ This is the first systematic review of the impact
of assisted reproductive technology on asthma
and allergy in offspring, and it will provide a
comprehensive synthesis of the underlying evi-
dence base.
▪ The identification of studies from leading
medical and public health databases, with no
geographical or language limitations, will
advance import of this evidence synthesis across
settings.
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ﬁndings, some studies have suggested that ART children
are at increased risk of key perinatal outcomes, includ-
ing congenital malformations, prematurity, low birth
weight, hypertensive disease, diabetes, perinatal mortal-
ity, imprinting disorders and certain cancers.1–6
However, some investigators suggest that these observa-
tions may be a consequence of potential biases inherent
in observational epidemiological studies, underlying
maternal factors such as subfertility, age and parity, or a
combination of these factors and ART, and not necessar-
ily the ART procedure alone.1 2 7
Recently, some studies have investigated the relation-
ship between ART and the risk of asthma and atopic dis-
orders in children conceived through ART compared
with that in children conceived naturally, but ﬁndings
are conﬂicting.8–15 While the possible biological mech-
anism for these associations, as in other perinatal out-
comes, has not been clearly addressed, some argue that
the observed associations may be attributed to maternal
subfertility, residual confounding, or other immune
modifying maternal factors during pregnancy, such as
pre-existing conditions including but not limited to
asthma and allergy, or other extrinsic factors such as med-
ications and smoking.16 Furthermore, it has been sug-
gested that, since women undergoing ART procedures
are generally of higher socioeconomic status, and have
higher body mass with increased prevalence of metabolic
disorders, their offspring may be at an increased risk of
adverse outcomes.16 The high prevalence of metabolic
impairment in the infertile patient population may there-
fore have long-term transgenerational impact, either
through genetic or epigenetic mechanisms as a result of
embryo culture and the potency of the fertility drugs
used for treating resultant ovarian hyperstimulation.16 17
Given the increasing number of studies relating ART
to asthma and atopic disease in the offspring and mixed
ﬁndings now being observed, a comprehensive synthesis
of these studies is essential in order to clearly appreciate
the underlying evidence relating ART to the aetiology
and outcomes of asthma and atopic disease in the off-
spring. A synthesis of the evidence base will also help to
identify relevant gaps in research in this area and
suggest key steps in addressing these gaps. Therefore, in
this study, we aim to identify, critically appraise and syn-
thesise the evidence on the use of ART, and the risk of
asthma and atopic disease in the offspring.
METHODS
We have followed the recommendations of the Preferred
Reporting Items for Systematic review and Meta-Analysis
Protocols (PRISMA-P) checklist in reporting this
protocol.18
Eligibility criteria
Types of studies
We will include all analytic observational epidemio-
logical studies (cohort studies; case–control studies; and
cross-sectional studies) that have been conducted on the
topic. We will exclude reviews, case studies and case
series and animal studies.
Participants
Eligible participants will include women with evidence
of conception history and their offspring of any age.
Years considered
Given that the ﬁrst ART procedure was undertaken in
1978,1 2 we will consider all evidence emanating from
this date up to 2016.
Language
There will be no language restrictions and, where pos-
sible, we will translate the literature published in lan-
guages other than English.
Information sources
Database searches and other sources to identify studies
We will search MEDLINE, EMBASE, Cochrane Library,
ISI Web of Science, CINAHL, Scopus, Google Scholar,
AMED, Global Health, PsychINFO, CAB International
and the WHO Global Health Library. The databases will
be searched for studies indexed from 1978 until 2016.
We will locate additional references through searching
the references cited in identiﬁed studies; through
searching databases of the proceedings of international
conferences, such as ISI Conference Proceedings
Citation Index via Web of Knowledge, ZETOC (British
Library); and by contacting a panel of international
experts and authors who have published in the ﬁeld. We
will search trial registries, such as Current Controlled
Trials (http://www.controlled-trials.com), ClinicalTrials.
gov (http://www.clinicaltrials.gov) and Australian and
New Zealand Clinical Trials Registry (http://www.anzctr.
org.au), to identify ongoing studies.
Search strategy
Using the Ovid interface for MEDLINE, we have devel-
oped a highly sensitive and comprehensive search strat-
egy (see online supplementary appendix 1) to identify
and retrieve relevant and eligible studies. This search
strategy will be adapted in searching the other databases.
Study records
Data management
The retrieved records from all databases will be exported
to Endnote Library, which will be used throughout the
review for study screening, deduplication and overall
management of the retrieved records.
Selection process
Titles and abstracts of retrieved articles will be screened
and full text copies of potentially eligible studies
assessed by two independent reviewers; a third reviewer
will arbitrate any discrepancies. Studies that do not fulﬁl
the inclusion criteria will be excluded.
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Data extraction
Two reviewers will independently extract relevant study
data from eligible studies onto a customised data extrac-
tion form; a third reviewer will arbitrate any discrepan-
cies. Before using the form for all studies, we will pilot
the data extraction form with a selected sample of
studies in order to evaluate the ability of the form to
capture the relevant study data of interest.
Data items
Descriptive summary tables will be produced to summar-
ise the literature and we will tabulate all relevant study
data. In addition to other relevant study data as may be
available from each study, we aim to capture, as a
minimum, the following data items from each study:
study author; country of study; year of publication; type of
study design; study size; source of study population; type
of ART (and comparison group) and method of assess-
ment; singleton versus multiple pregnancy; length of
follow-up (for follow-up studies); key potential confoun-
ders (maternal age, parity, subfertility, history of asthma/
allergy, maternal smoking during pregnancy and sex of
child); study outcomes and methods of assessment; ana-
lysis methods; and key results. The PRISMA checklist will
guide the reporting of the systematic review.19
Types of exposures
We will include all studies that have investigated the role
of any type of ART (in vitro fertilisation, intrauterine
insemination, intracytoplasmic sperm injection, zygote
intrafallopian transfer, gamete intrafallopian transfer,
medicinal and surgical infertility treatments) in compari-
son with natural conception or any other comparison
group as reported in the studies.
Outcomes and prioritisation
Our primary outcomes will include: objectively measured or
self-reported asthma, atopic dermatitis/eczema, allergic
rhinitis, anaphylaxis, urticaria, angio-oedema and food
allergy. The secondary outcomes will include: atopic sensi-
tisation as deﬁned either by skin prick test or raised antigen-
speciﬁc IgE; objective and subjective measures of disease
severity and impact on quality of life, including asthma
exacerbations, use of asthma medications, hospitalisation
for asthma, wheeze as deﬁned by self-report or objective
diagnosis; indicators of airway function (including peak
expiratory ﬂow, forced expiratory volume in 1 s, forced vital
capacity, forced expiratory ﬂow rate or alternative age appro-
priate pulmonary function tests (oscillometry or exhaled
nitric oxide analysis)); and measures of patient-reported
health-related quality of life related to asthma or allergy.
Risk of bias in individual studies
Risk of bias in eligible studies will be assessed by two
reviewers; a third reviewer will arbitrate any discrepan-
cies. We will assess the risk of bias by using the Effective
Public Health Practice Project (EPHPP) tool (http://
www.ephpp.ca). We will grade the following components
of each study: suitability of the study design for the
research question; risk of selection bias; exposure meas-
urement; outcome assessment; and generalisability of
ﬁndings. From these component-speciﬁc assessments, we
will derive an overall grading for each study.
Data synthesis
To summarise the overall evidence, we will undertake a
narrative synthesis of the data. Additionally, for clinically,
methodologically and statistically homogeneous studies,
we will perform meta-analyses using random-effects
models to quantify a pooled estimate of the effect of spe-
ciﬁc types of ART on the risk of asthma and atopic
disease in the offspring. Meta-analyses will be undertaken
separately for each speciﬁc study design. In comparison
with ﬁxed-effect meta-analysis, using random-effects
models to compute the pooled estimates presents a more
conservative option, as the underlying assumption of
random-effects meta-analysis of non-common effect
across studies is more realistic when involving studies
obtained solely from the published literature.20 The
random-effects model also takes into account potential
heterogeneity between studies when computing the
pooled estimates.20 We will quantify the heterogeneity
between studies using the I2 statistic. We will undertake
the following subgroup analyses: by age of offspring at
onset/diagnosis of outcomes (where possible using the
following age groups: <5 years, 5–12 years, >12 years);
singleton versus multiple pregnancy; single versus double
embryo transfers; parity; and length of subfertility. We will
undertake a sensitivity analysis by the grading of study
quality in order to evaluate the robustness of our ﬁnd-
ings. The meta-analyses will be performed using the Stata
14 statistical package (StataCorp. 2015. Stata Statistical
Software: Release 14. College Station, TX: StataCorp LP).
Publication bias
We will evaluate the potential for publication bias by
using funnel plots and Begg and Egger tests.21 22
Protocol registration
A detailed protocol for the review is registered with
the International Prospective Register of Systematic
Reviews (PROSPERO): 2016:CRD42016035966 (http://
www.crd.york.ac.uk/PROSPERO/display_record.asp?
ID=CRD42016035966).
Confidence in the cumulative estimate
We will evaluate the strength of the overall evidence
through assessment of the clinical and methodological het-
erogeneity across studies and on the basis of the risk of bias
assessment in included studies. We will consider these lines
of impact on the overall evidence in reaching a conclusion
on the import of ﬁndings and in recommending for future
direction in the ﬁeld. Furthermore, we will grade the
strength and quality of the overall evidence by using the
Grading of Recommendations Assessment, Development
and Evaluation (GRADE) approach.23
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CONCLUSION
The increasing use of ART and its potential implication
for increased risk of asthma and atopic disease in the
offspring now requires a comprehensive evidence syn-
thesis, which will provide us with the opportunity to
appreciate the underlying evidence base and assess its
policy, practice and public health implications. In add-
ition, this evidence synthesis provides the opportunity
to identify the research gaps in studies linking ART to
the development of asthma and atopic disease in the
offspring. We aim to report the ﬁndings from this
review by autumn 2016.
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